Lanping Zhu Selected Research

transgelin

1/2023	Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma.
1/2022	Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial-Mesenchymal Transition.
1/2021	Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial-Mesenchymal Transition.
1/2020	Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lanping Zhu Research Topics

Disease

2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2021
2	Ulcerative Colitis 01/2021 - 01/2021
2	Neoplasms (Cancer) 01/2021 - 01/2020
1	Anorexia 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Esophageal Squamous Cell Carcinoma 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

4	transgelinIBA 01/2023 - 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2023
1	CausticsIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2023
1	lafutidineIBA 01/2023
1	AlbuminsIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Therapeutic UsesIBA 01/2021
1	phellodendrineIBA 01/2021
1	Cartilage Oligomeric Matrix ProteinIBA 01/2020
1	chrysinIBA 01/2020